
Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy
Keywords: DNA methylation; HYAL2; Predictive marker; Prognostic marker; Colorectal cancer; Chemotherapy; 5-FU